TC Biopharm (Holdings) Plc
TCBP · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $684,992 | $487,881 | $371,931 | $1,051,886 |
| - Cash | $1,004 | $981 | $2,463 | $2,463 |
| + Debt | $1,654 | $1,728 | $1,496 | $1,496 |
| Enterprise Value | $685,641 | $488,629 | $370,965 | $1,050,919 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,934 | -$3,315 | -$3,133 | -$3,133 |
| % Margin | – | – | – | – |
| Net Income | -$1,987 | -$3,322 | -$3,130 | -$3,130 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -1.4 | -3.36 | -3.36 |
| % Growth | 78.6% | 58.3% | 0% | – |
| Operating Cash Flow | -$2,733 | -$2,409 | -$1,997 | -$1,997 |
| Capital Expenditures | -$30 | -$6 | $24 | $24 |
| Free Cash Flow | -$2,763 | -$2,414 | -$1,972 | -$1,972 |